As we face the unprecedented health crisis caused by the global spread of the coronavirus, all members of our Center for Infertility and Reproductive Surgery at Brigham and Women’s Hospital recognize and appreciate the heroic response of the physicians, nurses and staff who are caring for those who have contracted this dreadful disease. We are fully committed to using the resources in our hospital to assist in the community effort to combat Covid-19.
While we recognize that the current crisis is particularly challenging to our fertility patients, we are balancing the Governor’s restriction on travel outside the home and the need to conserve valuable hospital resources.
Available Services for New and Existing Patients
Our office are open for the following services:
In-person procedural office visits
Intrauterine insemination (IUI)
Fertility preservation for cancer patients facing urgent cancer treatment
Telemedicine consultations: A telemedicine appointment can be coordinated with one of our physicians whether you are a new or existing patient. Telemedicine is a wonderful way to connect with your physician and to develop a diagnostic plan or to decide on a treatment option.
We will resume in vitro fertilization (IVF) on June 1. Other elective surgeries remain paused at this time.
To make a telemedicine appointment, please call one of the following:
617-732-4222, if either Brigham and Women’s Hospital or our Foxborough satellite is your most convenient location
Appointments may also be booked via one of our satellite locations:
Stratham, NH in collaboration with Exeter Hospital (603-773-6973)
Newton-Wellesley Hospital (617-243-5200)
Weymouth, MA (617-682-4564)
If you are an existing patient, you may also utilize Patient Gateway to connect with your doctor or nurse.
Updates and Returning to Full Operations
We are committed to providing timely and safe care as soon as possible. We are here to help and support you, so please do not hesitate to contact us, whatever your question or concern.
As we continue to open for more services, we will message existing patients through Patient Gateway. We will also update this page with information as it becomes available.
FAQs for Infertility Patients
Does COVID-19 impact fertility or pregnancy? There is little data at present on the effect of COVID-19 on fertility, pregnancy and the newborn, but preliminary observations to date suggest that there is no significant impact.
How will you ensure that my eggs/embryos/sperm will remain safe in the lab? Frozen eggs, embryos and sperm are safely stored in individual containers in liquid nitrogen tanks. The tanks continue to be carefully monitored by laboratory staff.
Can my new patient consultation be held effectively via telemedicine? Yes. Similar to an in-person new patient consult, our providers will speak with you about your concerns and discuss options for treatment.
When will I be able to resume treatment with CIRS? At this time, our offices are open for procedural office visits, laboratory testing and intrauterine insemination. We will resume IVF on June 1. We will continue to update all existing and new patients via this site with timely information as it becomes available.
Who should I call if I have a question about my care? For questions about your care, please call the center at which you normally receive your care at one of the phone numbers above. Our nurses and doctors will help you.
Where can I find additional information about COVID-19 and Fertility Treatment? For more information, please visit the American Society for Reproductive Medicine’s FAQs for Patients Related to COVID-19.